絞り込み

16573

広告

2919件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

The effect of DOAC-Stop on lupus anticoagulant testing in plasma samples of venous thromboembolism patients receiving direct oral anticoagulants.

Use of direct oral anticoagulants in very elderly patients: a case report of apixaban in an ultracentenary patient.

Apixaban and Rivaroxaban in Patients With Acute Venous Thromboembolism.

Atrial Fibrillation.

Discontinuation and primary care visits in nonvalvular atrial fibrillation patients treated with apixaban or warfarin.

Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.

Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature.

Shorter hospital stays in epistaxis patients with atrial fibrillation when taking rivaroxaban or apixaban versus phenprocoumon.

Reversal strategies in patients treated with direct oral anticoagulants.

Betrixaban for Extended Venous Thromboembolism Prophylaxis in High-Risk Hospitalized Patients: Putting the APEX Results into Practice.

Bleeding Risk of Add-On Anti-Platelet Agents to Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation (From 2216 Patients in the DIRECT Registry).

Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients Undergoing Interventional Techniques: American Society of Interventional Pain Physicians (ASIPP) Guidelines.

Safety of direct oral anticoagulants in real world clinical practice: translating the trials to everyday clinical management.

Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program.

An Underappreciated and Prolonged Drug Interaction Leads to Ineffective Anticoagulation.

Safety of new oral anticoagulants for patients with chronic kidney disease".

Clinical impact of direct oral anticoagulant measuring in a real-life setting.

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays.

Progress in the monitoring of direct oral anticoagulant therapy.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります